Literature DB >> 19048401

Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr Virus positive and negative pediatric non-Hodgkin's lymphoma.

Safiye Aktaş1, Aydanur Kargi, Nur Olgun, Gulden Diniz, Ayşe Erbay, Canan Vergin.   

Abstract

Apoptosis-related proteins and proliferation activity and their relationship with Epstein-Barr Virus (EBV) are contemporary issues in pediatric non-Hodgkin's lymphoma (pNHL). In this study prognostic or pathogenetic role of EBV latent infection, proliferating activity, and apoptosis-regulating proteins in pNHL were explored. EBV-EBER, lmp-1, ki-67, bcl-2, survivin, bax, fas, c-myc, p53 and apoptotic index by TUNEL method were explored in 70 pNHL cases and evaluated statistically. Of the 70 cases evaluated, 24 were female and 46 were male. Seven cases were stage I/II and 63 cases were stage III/IV. The mean age was 7.16 + or - 3.72(1-15). EBV was positive in (25.7%) cases. Overall survival was 82%, while event free survival was 75%. Bax was expressed in 40% of the cases, while the expression of bcl-2,was 50%, survivin 42.9%, p53 8.6%, fas 18.6% and c-myc in 45.7%. Mean apoptotic index was 131.29 + or - 96.69 per 5,000 cells. Mean proliferation index was 55.97% (12-92%). Fas positivity was high in EBV positive cases (p = 0.0001). EBV positivity was not related with prognosis. Apoptotic index was found to be an independent prognostic factor (p = 0.017). Our results suggest that apoptosis-regulating proteins have a role in the pathogenesis of pNHL. EBV was correlated with apoptotic index and fas, bcl-2. No correlation was observed with proliferation index and studied factors. High apoptotic index was related with good prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19048401     DOI: 10.1007/s12253-008-9127-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  35 in total

1.  Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists.

Authors:  Kikkeri N Naresh; Beamon Agarwal; Bharat N Nathwani; Jacques Diebold; Kenneth A McLennan; Konrad H Muller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  Leuk Lymphoma       Date:  2004-08

2.  Intrinsic apoptotic pathway in anaplastic large cell lymphoma.

Authors:  Mauricio P Oyarzo; Elias Drakos; Coralyn Atwell; Hesham M Amin; L Jeffrey Medeiros; George Z Rassidakis
Journal:  Hum Pathol       Date:  2006-05-26       Impact factor: 3.466

3.  Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.

Authors:  G Z Rassidakis; A H Sarris; M Herling; R J Ford; F Cabanillas; T J McDonnell; L J Medeiros
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.

Authors:  Paola A Chabay; Elena N De Matteo; Luis Aversa; Silvana Maglio; Saúl Grinstein; María Victoria Preciado
Journal:  Arch Pathol Lab Med       Date:  2002-03       Impact factor: 5.534

5.  Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries.

Authors:  C R Rao; M I Gutierrez; K Bhatia; F Fend; J Franklin; L Appaji; G Gallo; G O'Conor; N Lalitha; I Magrath
Journal:  Leuk Lymphoma       Date:  2000-10

6.  p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.

Authors:  K B Pagnano; J Vassallo; I Lorand-Metze; F F Costa; S T Saad
Journal:  Am J Hematol       Date:  2001-06       Impact factor: 10.047

Review 7.  Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology.

Authors:  Katsushi Nakayama; Shimeru Kamihira
Journal:  Leuk Lymphoma       Date:  2002-12

8.  Molecular analysis and pathology of a second pediatric HIV-associated Burkitt lymphoma.

Authors:  Eve Cabalo; Robert Wilkinson; Nu T Lu; Sheri Shimizu; Marian Melish; Kenneth L McClain; Hal B Jenson; Bruce Shiramizu
Journal:  Pediatr Pathol Mol Med       Date:  2002 Nov-Dec

9.  Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines.

Authors:  A D Wennborg; E Altiok; J P Moore; I Ernberg; G Klein
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

10.  BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.

Authors:  George Z Rassidakis; Dan Jones; Raymond Lai; Preetha Ramalingam; Andreas H Sarris; Timothy J McDonnell; L Jeffrey Medeiros
Journal:  J Pathol       Date:  2003-06       Impact factor: 7.996

View more
  2 in total

1.  Prognostic significance of survivin and caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP.

Authors:  Zdravko Mitrović; Ivana Ilić; Igor Aurer; Sandra Bašić Kinda; Ivo Radman; Snježana Dotlić; Radmila Ajduković; Boris Labar
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-03       Impact factor: 0.196

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.